SEC Form 4 · accession 0001179110-16-029192
Traws Pharma, Inc. · TRAW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ramesh Kumar
Officer — President and CEO · Director
Period of report
Sep 1, 2016
Accepted (ET)
Sep 1, 2016 · 3:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001130598
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to purchase)F1 | $3.24 | Sep 1, 2016 | A | 44,000 | A | — | Sep 1, 2026 | Common Stock | 44,000 | 44,000 | D |
Explanation of responses
- F1These options vest over three years in 36 equal monthly installments.